Find the latest oncology news for your sub-specialty area
ASCO 2017: CAR T-Cell Therapy Sends Multiple Myeloma Into Lasting Remission
In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of multiple myeloma upon receiving a new type of…